Cestode Infections¶
Chapter 242 | Part 5: Infectious Diseases
KEY CLINICAL POINTS¶
- Praziquantel (10 mg/kg) is the drug of choice for Taenia solium, Taenia saginata, and neurocysticercosis.
- Neurocysticercosis diagnosis requires imaging (MRI/CT) and serology, with Table 242-1 outlining revised diagnostic criteria.
- Echinococcosis (hydatid disease) is caused by Echinococcus granulosus sensu lato, with imaging (ultrasound, CT, MRI) as the primary diagnostic tool.
- Rodentolepis nana (dwarf tapeworm) is the most common human cestode infection, transmitted via fecal-oral route.
- Diphyllobothriasis is caused by broad fish tapeworms (Dibothriocephalus latus, etc.), requiring fish cooking/freezing for prevention.
1. DEFINITION & OVERVIEW¶
Cestodes (tapeworms) are flatworms in the phylum Platyhelminthes. Humans are definitive hosts for adult tapeworms (e.g., Taenia saginata, Taenia solium) or intermediate hosts for larval forms (e.g., Echinococcus granulosus). Infections include tapeworm (adult) and larval (cysticercosis, hydatid disease) forms.
Table 242-1 Revised Diagnostic Criteria for Neurocysticercosis¶
| Criteria Type | Major Criteria | Confirmatory Criteria | Minor Criteria |
|---|---|---|---|
| Absolute Criteria | Histologic demonstration of parasite | Visualization of subretinal cysticercus | Conclusive demonstration of scolex on neuroimaging |
| Neuroimaging Criteria | Cystic lesions without scolex, parenchymal calcifications | Resolution of cysts after treatment | Obstructive hydrocephalus or basal meningeal enhancement |
| Clinical/Exposure Criteria | Specific anticysticercal antibodies (EITB), cysticercosis outside CNS | Household contact with T. solium | Clinical symptoms suggestive of neurocysticercosis |
1.1 Cestode Life Cycle¶
Adult tapeworms reside in the human intestine. Larval stages (cysticerci) develop in intermediate hosts (e.g., pigs for T. solium, rodents for E. multilocularis). Humans may be accidental hosts for larval stages, leading to cysticercosis or echinococcosis.
1.2 Common Species¶
Key species include Taenia saginata (beef tapeworm), Taenia solium (pork tapeworm), Echinococcus granulosus (hydatid tapeworm), Echinococcus multilocularis (alveolar echinococcosis), and Rodentolepis nana (dwarf tapeworm).
2. EPIDEMIOLOGY¶
Taenia solium is endemic in Latin America, sub-Saharan Africa, China, India, and Southeast Asia. Echinococcosis (E. granulosus) is prevalent in areas with livestock and dogs. Rodentolepis nana is globally distributed, with person-to-person transmission via fecal-oral route. Diphyllobothriasis occurs in freshwater fish-consuming regions.
2.1 Risk Factors¶
Consumption of undercooked pork (T. solium), raw fish (Diphyllobothriasis), contaminated food/water (R. nana), and close contact with tapeworm carriers (T. solium).
2.2 Demographics¶
T. solium: Endemic in developing countries; R. nana: Common in children; Echinococcosis: High prevalence in rural areas with livestock and dogs.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Taenia solium larvae (cysticerci) form cysts in tissues (neurocysticercosis). Echinococcus granulosus larvae form hydatid cysts in organs. Rodentolepis nana eggs hatch into oncospheres, developing into cysticercoids in the intestine. Diphyllobothrium larvae develop in fish and infect humans via raw consumption.
3.1 Molecular Mechanisms¶
Echinococcus larvae secrete antigens that modulate host immunity, leading to granuloma formation. T. solium cysticerci cause inflammation and tissue damage via immune response.
3.2 Pathogenesis¶
Cysticerci release antigens causing inflammation and granuloma formation. Hydatid cysts grow slowly, with daughter cysts forming brood capsules. Neurocysticercosis can cause seizures, hydrocephalus, or meningitis.
4. CLINICAL FEATURES¶
Symptoms vary by infection type: neurocysticercosis (seizures, hydrocephalus), echinococcosis (abdominal pain, liver masses), R. nana (asymptomatic or mild GI symptoms), Diphyllobothriasis (vitamin B12 deficiency).
4.1 Neurocysticercosis¶
Seizures (most common), hydrocephalus, meningitis, or focal neurological deficits. Cysts may calcify, leading to chronic symptoms.
4.2 Echinococcosis¶
Liver or lung involvement (asymptomatic initially), biliary obstruction, or mass effect. Alveolar echinococcosis (E. multilocularis) mimics malignancy.
5. DIFFERENTIAL DIAGNOSIS¶
Neurocysticercosis vs. tuberculosis, brain tumors, or other CNS infections. Echinococcosis vs. liver cancer or abscesses. R. nana vs. other intestinal parasites. Diphyllobothriasis vs. vitamin B12 deficiency.
6. INVESTIGATIONS & DIAGNOSIS¶
Stool examination for eggs/proglottids, neuroimaging (MRI/CT for neurocysticercosis), serology (ELISA, EITB), and ultrasound/CT for echinococcosis. Imaging classification (CE1-CE5) guides management.
6.1 Diagnostic Imaging¶
MRI/CT for neurocysticercosis (scolex identification), ultrasound/CT for echinococcosis (cyst morphology).
6.2 Serology¶
ELISA and immunoblot for specific antibodies. Antigen detection in CSF/serum for active infections.
7. MANAGEMENT & TREATMENT¶
Praziquantel (10 mg/kg) for Taenia solium, neurocysticercosis, and Diphyllobothriasis. Albendazole (15 mg/kg) for echinococcosis. PAIR (aspiration, instillation, reaspiration) for liver cysts. Surgery for complicated cases.
Table 242-1 Revised Diagnostic Criteria for Neurocysticercosis¶
| Criteria Type | Major Criteria | Confirmatory Criteria | Minor Criteria |
|---|---|---|---|
| Absolute Criteria | Histologic demonstration of parasite | Visualization of subretinal cysticercus | Conclusive demonstration of scolex on neuroimaging |
| Neuroimaging Criteria | Cystic lesions without scolex, parenchymal calcifications | Resolution of cysts after treatment | Obstructive hydrocephalus or basal meningeal enhancement |
| Clinical/Exposure Criteria | Specific anticysticercal antibodies (EITB), cysticercosis outside CNS | Household contact with T. solium | Clinical symptoms suggestive of neurocysticercosis |
7.1 Neurocysticercosis¶
Antiseizure meds first. Antiparasitics (praziquantel/albendazole) for viable cysts. Corticosteroids for inflammation. Shunting for hydrocephalus.
7.2 Echinococcosis¶
Albendazole (15 mg/kg) for 2–6 months. PAIR for small cysts. Surgery for large or symptomatic lesions.
8. PROGNOSIS & COMPLICATIONS¶
Neurocysticercosis: Seizures may persist despite treatment. Echinococcosis: Chronic, with risk of rupture or secondary infections. R. nana: Usually benign but may cause autoinfection. Diphyllobothriasis: Vitamin B12 deficiency if untreated.
8.1 Complications¶
Hydrocephalus, meningitis, biliary obstruction, or anaphylaxis from cyst rupture. Alveolar echinococcosis is life-threatening without surgery.
8.2 Mortality¶
Low for most infections; high for alveolar echinococcosis or severe neurocysticercosis with complications.
9. SPECIAL CONSIDERATIONS¶
Pregnancy: Avoid antiparasitics due to teratogenic risk. Pediatrics: R. nana is common in children. Elderly: Higher risk of complications from neurocysticercosis. Immunocompromised: Increased risk of disseminated infections.
9.1 Pregnancy¶
Avoid antiparasitics; manage symptoms with corticosteroids and anticonvulsants.
9.2 Pediatrics¶
R. nana is prevalent; asymptomatic infections common. Monitor for autoinfection.
10. KEY POINTS & CLINICAL PEARLS¶
- Praziquantel is the first-line treatment for most cestode infections. 2. Neurocysticercosis requires neuroimaging and serology for diagnosis. 3. Echinococcosis is managed with albendazole and surgery. 4. Prevention includes proper cooking of meat and improved sanitation. 5. PAIR is effective for liver cysts but requires experienced intervention.